Search

everythinglearnresearchcommunity

for

Search:↓

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Dutasteride may reduce insulin sensitivity and increase body fat.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Heptaminol may cause hair lightening in hemodialysis patients.

Minoxidil in FOAMIL is stable for at least 180 days at various concentrations.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Apremilast showed mixed results for treating severe alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Spironolactone successfully treated hair loss in a 9-year-old girl.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

The drug combination was safe and showed promise in treating advanced tumors.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.